{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:54:18Z","timestamp":1790715258571,"version":"4.1.0"},"reference-count":306,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Breast cancer is one of the most common malignancy among women worldwide. Metastasis is mainly responsible for treatment failure and is the cause of most breast cancer deaths. The role of metabolism in the progression and metastasis of breast cancer is gradually being emphasized. However, the regulatory mechanisms that conduce to cancer metastasis by metabolic reprogramming in breast cancer have not been expounded. Breast cancer cells exhibit different metabolic phenotypes depending on their molecular subtypes and metastatic sites. Both intrinsic factors, such as <jats:italic>MYC<\/jats:italic> amplification, <jats:italic>PIK3CA<\/jats:italic>, and <jats:italic>TP53<\/jats:italic> mutations, and extrinsic factors, such as hypoxia, oxidative stress, and acidosis, contribute to different metabolic reprogramming phenotypes in metastatic breast cancers. Understanding the metabolic mechanisms underlying breast cancer metastasis will provide important clues to develop novel therapeutic approaches for treatment of metastatic breast cancer.<\/jats:p>","DOI":"10.3389\/fonc.2020.602416","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:34:20Z","timestamp":1609994060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":132,"title":["The Metabolic Mechanisms of Breast Cancer Metastasis"],"prefix":"10.3389","volume":"10","author":[{"given":"Lingling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.05.022","article-title":"Is Cancer a Genetic Disease or a Metabolic Disease","volume":"2","author":"Wishart","year":"2015","journal-title":"EBioMedicine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i1.122","article-title":"Targeting metabolism in breast cancer: How far we can go","volume":"7","author":"Long","year":"2016","journal-title":"World J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004710","article-title":"Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the \u201cbasal\u201d breast cancer subgroup","volume":"4","author":"Alles","year":"2009","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0594-8","article-title":"High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation","volume":"122","author":"Antalis","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3894","article-title":"Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression","volume":"71","author":"Hilvo","year":"2011","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.01.182","article-title":"Secreted phospholipases A(2)are differentially expressed and epigenetically silenced in human breast cancer cells","volume":"445","author":"Brglez","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101004","article-title":"Differential expression of enzymes associated with serine\/glycine metabolism in different breast cancer subtypes","volume":"9","author":"Kim","year":"2014","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.387","article-title":"MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer","volume":"118","author":"Craze","year":"2018","journal-title":"Br J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tem.2018.10.006","article-title":"Crosstalk between Estrogen Signaling and Breast Cancer Metabolism","volume":"30","author":"Kulkoyluoglu-Cotul","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9369358","article-title":"Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer","volume":"2018","author":"Choi","year":"2018","journal-title":"Dis Markers"},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000339513","article-title":"Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry","volume":"80","author":"Choi","year":"2013","journal-title":"Pathobiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0398","article-title":"Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer","volume":"20","author":"Kim","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119473","article-title":"Differential expression of lipid metabolism-related proteins in different breast cancer subtypes","volume":"10","author":"Kim","year":"2015","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501555112","article-title":"Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP","volume":"112","author":"Shen","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13058-014-0434-6","article-title":"Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential","volume":"16","author":"Pelicano","year":"2014","journal-title":"Breast Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.09.002","article-title":"Metabolic crosstalk in the breast cancer microenvironment","volume":"121","author":"Dias","year":"2019","journal-title":"Eur J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9746","article-title":"Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18175","article-title":"The reverse Warburg effect is likely to be an Achilles\u2019 heel of cancer that can be exploited for cancer therapy","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/bcr3472","article-title":"Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype","volume":"15","author":"Choi","year":"2013","journal-title":"Breast Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201695204","article-title":"Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype","volume":"36","author":"Semenza","year":"2017","journal-title":"EMBO J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(03)00010-7","article-title":"Differential expression of GLUT12 in breast cancer and normal breast tissue","volume":"193","author":"Rogers","year":"2003","journal-title":"Cancer Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20606","article-title":"Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues","volume":"207","author":"Godoy","year":"2006","journal-title":"J Cell Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-012-9500-5","article-title":"Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1558","article-title":"17beta-estradiol activates glucose uptake via GLUT4 translocation and PI3K\/Akt signaling pathway in MCF-7 cells","volume":"154","author":"Garrido","year":"2013","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023205","article-title":"Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo","volume":"6","author":"Young","year":"2011","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000217568","article-title":"Glycolytic enzyme activities in breast cancer metastases","volume":"9","author":"Hennipman","year":"1988","journal-title":"Tumour Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.229","article-title":"Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth","volume":"28","author":"Zhao","year":"2009","journal-title":"Oncogene"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21601","article-title":"Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome","volume":"8","author":"Benito","year":"2017","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.358","article-title":"Q\u2019s next: the diverse functions of glutamine in metabolism, cell biology and cancer","volume":"29","author":"DeBerardinis","year":"2010","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-319-77736-8_2","article-title":"Glutamine Metabolism in Cancer","volume":"1063","author":"Li","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109014200","article-title":"c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism","volume":"276","author":"Eberhardy","year":"2001","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/15384101.2015.1120930","article-title":"Lactate promotes glutamine uptake and metabolism in oxidative cancer cells","volume":"15","author":"Perez-Escuredo","year":"2016","journal-title":"Cell Cycle"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29152","article-title":"Glutamate enrichment as new diagnostic opportunity in breast cancer","volume":"136","author":"Budczies","year":"2015","journal-title":"Int J Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.nutr.012809.104810","article-title":"Compartmentalization of Mammalian folate-mediated one-carbon metabolism","volume":"30","author":"Tibbetts","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br J Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.2.311","article-title":"New insights into the regulation of methyl group and homocysteine metabolism","volume":"137","author":"Williams","year":"2007","journal-title":"J Nutr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-019-0394-0","article-title":"Folate intake and the risk of breast cancer: an up-to-date meta-analysis of prospective studies","volume":"73","author":"Zeng","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.05.002","article-title":"The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO","volume":"35","author":"Mondanelli","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2003.09.002","article-title":"Arginase in patients with breast cancer","volume":"338","author":"Cavdar","year":"2003","journal-title":"Clin Chim Acta"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00293","article-title":"Obesity and Breast Cancer: Current Insights on the Role of Fatty Acids and Lipid Metabolism in Promoting Breast Cancer Growth and Progression","volume":"8","author":"Blucher","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605007","article-title":"De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy","volume":"100","author":"Mashima","year":"2009","journal-title":"Br J Cancer"},{"key":"B59","article-title":"Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer","volume":"4","author":"Wang","year":"2004","journal-title":"J Exp Ther Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21917","article-title":"The tyrosine kinase receptor HER2 (erbB-2): from oncogenesis to adipogenesis","volume":"105","author":"Vazquez-Martin","year":"2008","journal-title":"J Cell Biochem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.040574197","article-title":"Sterol regulation of human fatty acid synthase promoter I requires nuclear factor-Y- and Sp-1-binding sites","volume":"97","author":"Xiong","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/01635580802348666","article-title":"Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells","volume":"61","author":"Donnelly","year":"2009","journal-title":"Nutr Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.121","article-title":"AMP-activated protein kinase and human cancer: cancer metabolism revisited","author":"Kuhajda","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2489","article-title":"Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1","volume":"68","author":"Furuta","year":"2008","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/excr.2002.5600","article-title":"Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"279","author":"Yang","year":"2002","journal-title":"Exp Cell Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097697","article-title":"The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER\/HER2-positive breast cancer cells","volume":"9","author":"Yan","year":"2014","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","article-title":"Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms","volume":"11","author":"Pelon","year":"2020","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1478-811X-9-18","article-title":"Interaction of tumor cells with the microenvironment","volume":"9","author":"Ungefroren","year":"2011","journal-title":"Cell Commun Signal"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ncponc0685","article-title":"The clinical significance of disseminated tumor cells in breast cancer","volume":"4","author":"Slade","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa050434","article-title":"A pooled analysis of bone marrow micrometastasis in breast cancer","volume":"353","author":"Braun","year":"2005","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41698-018-0047-0","article-title":"Organotropism: new insights into molecular mechanisms of breast cancer metastasis","volume":"2","author":"Chen","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-007-9047-3","article-title":"Organotropism of breast cancer metastasis","volume":"12","author":"Lu","year":"2007","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2009.05.004","article-title":"Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy","volume":"19","author":"Huber","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.1574","article-title":"Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX","volume":"31","author":"Metzger-Filho","year":"2013","journal-title":"J Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3741-z","article-title":"A novel gene expression signature for bone metastasis in breast carcinomas","volume":"156","author":"Savci-Heijink","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Smid","year":"2008","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J Clin Oncol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cell.2011.11.016","article-title":"Cancer invasion and the microenvironment: plasticity and reciprocity","volume":"147","author":"Friedl","year":"2011","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3084","article-title":"Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)","volume":"47","author":"Huang","year":"2015","journal-title":"Int J Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0908-1021","article-title":"Twisted epithelial-mesenchymal transition blocks senescence","volume":"10","author":"Weinberg","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/cancers11101432","article-title":"Potential Role of MSC\/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation","volume":"11","author":"Hass","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.03.007","article-title":"New insights into the mechanisms of organ-specific breast cancer metastasis","volume":"22","author":"Lorusso","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.04.003","article-title":"Platelets, selectins, and the control of tumor metastasis","volume":"41","author":"Coupland","year":"2014","journal-title":"Semin Oncol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141602","article-title":"Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis","volume":"10","author":"Yadav","year":"2015","journal-title":"PloS One"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2010.04.005","article-title":"Selectins promote tumor metastasis","volume":"20","author":"Laubli","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.252","article-title":"Downregulation of CXCL12 in mesenchymal stromal cells by TGFbeta promotes breast cancer metastasis","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and Significance of the Pre-metastatic Niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9036-9","article-title":"Bone marrow cells in the \u2018pre-metastatic niche\u2019: within bone and beyond","volume":"25","author":"Kaplan","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B94","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s1535-6108(02)00153-8","article-title":"MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis","volume":"2","author":"Hiratsuka","year":"2002","journal-title":"Cancer Cell"},{"key":"B95","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-018-0761-z","article-title":"Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation","volume":"37","author":"Wu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/nrd795","article-title":"New therapeutics that modulate chemokine networks","volume":"1","author":"Schwarz","year":"2002","journal-title":"Nat Rev Drug Discovery"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9019-x","article-title":"The pivotal role of CXCL12 (SDF-1)\/CXCR4 axis in bone metastasis","volume":"25","author":"Wang","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113483108","article-title":"Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation","volume":"108","author":"Wong","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3613","article-title":"Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1","volume":"19","author":"Zhuang","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2137","article-title":"Mining gene expression profiles: expression signatures as cancer phenotypes","volume":"8","author":"Nevins","year":"2007","journal-title":"Nat Rev Genet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/bcr2831","article-title":"Signaling pathways in breast cancer metastasis - novel insights from functional genomics","volume":"13","author":"Blanco","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1590","article-title":"Molecular mechanisms of bone metastasis and associated muscle weakness","volume":"20","author":"Waning","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.11.002","article-title":"VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors","volume":"20","author":"Lu","year":"2011","journal-title":"Cancer Cell"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-568683","article-title":"Interaction of platelet-derived autotaxin with tumor integrin alphaVbeta3 controls metastasis of breast cancer cells to bone","volume":"124","author":"Leblanc","year":"2014","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.canlet.2016.06.007","article-title":"RUNX2 promotes breast cancer bone metastasis by increasing integrin alpha5-mediated colonization","volume":"380","author":"Li","year":"2016","journal-title":"Cancer Lett"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506517102","article-title":"Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway","volume":"102","author":"Kang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006896","article-title":"Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment","volume":"4","author":"Dunn","year":"2009","journal-title":"PloS One"},{"key":"B108","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1038\/s41598-017-09040-4","article-title":"Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1001\/archeurol.2009.98","article-title":"Leptomeningeal metastases in breast cancer","volume":"3","author":"Scott","year":"2013","journal-title":"Am J Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1385\/MB:27:2:169","article-title":"Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells","volume":"2","author":"Lee","year":"2004","journal-title":"Mol Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/path.4304","article-title":"Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain","volume":"232","author":"Avraham","year":"2014","journal-title":"J Pathol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13058-015-0665-1","article-title":"Breast cancer brain metastases: biology and new clinical perspectives","volume":"18","author":"Witzel","year":"2016","journal-title":"Breast Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080933","article-title":"Astrocytes directly influence tumor cell invasion and metastasis in vivo","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21022","article-title":"Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way","volume":"58","author":"Pukrop","year":"2010","journal-title":"Glia"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nature05760","article-title":"Mediators of vascular remodelling co-opted for sequential steps in lung metastasis","volume":"446","author":"Gupta","year":"2007","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.09.042","article-title":"Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis","volume":"17","author":"Christen","year":"2016","journal-title":"Cell Rep"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.035","article-title":"The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites","volume":"150","author":"Gao","year":"2012","journal-title":"Cell"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0487","article-title":"Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer","volume":"22","author":"Kimbung","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-012-1150-1","article-title":"Comparison of ER\/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment","volume":"138","author":"Liu","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-016-9780-3","article-title":"beta-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases","volume":"33","author":"Bleckmann","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12967-015-0425-0","article-title":"Mechanisms involved in breast cancer liver metastasis","volume":"13","author":"Ma","year":"2015","journal-title":"J Transl Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.09.069","article-title":"Breast cancer stem cells, EMT and therapeutic targets","volume":"453","author":"Kotiyal","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/nature15260","article-title":"Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells","volume":"526","author":"Lawson","year":"2015","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-018-0880-6","article-title":"Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs","volume":"25","author":"Liu","year":"2018","journal-title":"Breast Cancer"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0626","article-title":"Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties","volume":"65","author":"Ponti","year":"2005","journal-title":"Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25972","article-title":"Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia","volume":"118","author":"Carcereri de Prati","year":"2017","journal-title":"J Cell Biochem"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E11-04-0306","article-title":"Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer","volume":"22","author":"Wendt","year":"2011","journal-title":"Mol Biol Cell"},{"key":"B130","doi-asserted-by":"publisher","first-page":"12698","DOI":"10.1038\/s41598-017-12716-6","article-title":"The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence","volume":"7","author":"Gooding","year":"2017","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2933","article-title":"Does tumour dormancy offer a therapeutic target","volume":"10","author":"Goss","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.10.029","article-title":"Mechanisms governing metastatic dormancy and reactivation","volume":"155","author":"Giancotti","year":"2013","journal-title":"Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2015.08.005","article-title":"Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment","volume":"17","author":"Simoes","year":"2015","journal-title":"Neoplasia"},{"key":"B134","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells8020089","article-title":"Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications","volume":"8","author":"Gandhi","year":"2019","journal-title":"Cells"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.05.006","article-title":"Autophagy in tumour cell death","volume":"23","author":"Macintosh","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3137","article-title":"Adaptation of energy metabolism in breast cancer brain metastases","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metab"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.09.006","article-title":"PGC-1alpha Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs","volume":"26","author":"Andrzejewski","year":"2017","journal-title":"Cell Metab"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"B141","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jcmm.12004","article-title":"Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells","volume":"17","author":"Mimeault","year":"2013","journal-title":"J Cell Mol Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120958","article-title":"Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance","volume":"10","author":"Verduzco","year":"2015","journal-title":"PloS One"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2268","article-title":"Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.7b04527","article-title":"Unravelling the Metabolic Progression of Breast Cancer Cells to Bone Metastasis by Coupling Raman Spectroscopy and a Novel Use of Mcr-Als Algorithm","volume":"90","author":"Marro","year":"2018","journal-title":"Anal Chem"},{"key":"B145","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.celrep.2019.05.091","article-title":"Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis","volume":"27","author":"Hsu","year":"2019","journal-title":"Cell Rep"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136215","article-title":"Hepatic lipids promote liver metastasis","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"Bos","year":"2009","journal-title":"Nature"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0457","article-title":"Notch1 inhibition alters the CD44hi\/CD24lo population and reduces the formation of brain metastases from breast cancer","volume":"9","author":"McGowan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.02.006","article-title":"Notch signaling as a novel regulator of metabolism","volume":"26","author":"Bi","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B150","article-title":"Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells","volume":"77","author":"Sierra","year":"1997","journal-title":"Lab Invest"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201623","article-title":"Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain","volume":"5","author":"Xing","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-017-9864-8","article-title":"Metabolic advantages and vulnerabilities in brain metastases","volume":"34","author":"Ciminera","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322098111","article-title":"Human breast cancer metastases to the brain display GABAergic properties in the neural niche","volume":"111","author":"Neman","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.992217","article-title":"Metabolic Signatures of Human Breast Cancer","volume":"2","author":"Mishra","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgu175","article-title":"Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status","volume":"35","author":"Sandhu","year":"2014","journal-title":"Carcinogenesis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the Light: The Growing Complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.04.026","article-title":"Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence","volume":"149","author":"Li","year":"2012","journal-title":"Cell"},{"key":"B158","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/ncomms3935","article-title":"Tumour-associated mutant p53 drives the Warburg effect","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat Commun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-03-0846","article-title":"The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression","volume":"64","author":"Schwartzenberg-Bar-Yoseph","year":"2004","journal-title":"Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1724","article-title":"p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation","volume":"10","author":"Kawauchi","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22776","article-title":"Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53","volume":"272","author":"Mathupala","year":"1997","journal-title":"J Biol Chem"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a p53-inducible regulator of glycolysis and apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113884108","article-title":"Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1215","article-title":"p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2","volume":"72","author":"Contractor","year":"2012","journal-title":"Cancer Res"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1177\/1535370216641787","article-title":"Role of mitochondrial dysfunction in cancer progression","volume":"241","author":"Hsu","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1126\/science.1126863","article-title":"p53 regulates mitochondrial respiration","volume":"312","author":"Matoba","year":"2006","journal-title":"Science"},{"key":"B168","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gde.2016.02.007","article-title":"TP53 mutation, mitochondria and cancer","volume":"38","author":"Kamp","year":"2016","journal-title":"Curr Opin Genet Dev"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600461","article-title":"AIF deficiency compromises oxidative phosphorylation","volume":"23","author":"Vahsen","year":"2004","journal-title":"EMBO J"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401965","article-title":"Regulation of AIF expression by p53","volume":"13","author":"Stambolsky","year":"2006","journal-title":"Cell Death Differ"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/nm1001-1111","article-title":"Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells","volume":"7","author":"Hwang","year":"2001","journal-title":"Nat Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.04.024","article-title":"Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation","volume":"54","author":"Zhou","year":"2014","journal-title":"Mol Cell"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2172","article-title":"p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase","volume":"13","author":"Jiang","year":"2011","journal-title":"Nat Cell Biol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2010.03.004","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Feng","year":"2010","journal-title":"Trends Cell Biol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2007.10.009","article-title":"SREBPs: the crossroads of physiological and pathological lipid homeostasis","volume":"19","author":"Raghow","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2789-2","article-title":"Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers","volume":"143","author":"Sengupta","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.12.002","article-title":"Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis","volume":"21","author":"Yue","year":"2017","journal-title":"Cell Rep"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and one-carbon units: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201990","article-title":"Translational induction of the c-myc oncogene via activation of the FRAP\/TOR signalling pathway","volume":"17","author":"West","year":"1998","journal-title":"Oncogene"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"B184","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2005.12.016","article-title":"Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters","volume":"21","author":"Cheng","year":"2006","journal-title":"Mol Cell"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1037","article-title":"Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor","volume":"25","author":"Wang","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.02.004","article-title":"Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells","volume":"149","author":"Chen","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90283-6","article-title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1","volume":"269","author":"Semenza","year":"1994","journal-title":"J Biol Chem"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990020515","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208802","article-title":"PKB\/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP","volume":"24","author":"Porstmann","year":"2005","journal-title":"Oncogene"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol Cell"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/nature08268","article-title":"Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment","volume":"461","author":"Schafer","year":"2009","journal-title":"Nature"},{"key":"B196","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12885-020-06810-8","article-title":"Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer","volume":"20","author":"McCarthy","year":"2020","journal-title":"BMC Cancer"},{"key":"B197","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12282-017-0812-x","article-title":"Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K\/Akt\/mTOR in estrogen receptor-positive, HER2-negative breast cancer","volume":"25","author":"Araki","year":"2018","journal-title":"Breast Cancer"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2944","article-title":"Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K\/AKT\/mTOR pathway","volume":"31","author":"Hou","year":"2014","journal-title":"Oncol Rep"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2016.01.021","article-title":"Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling","volume":"111","author":"Zhou","year":"2016","journal-title":"Steroids"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.414","article-title":"mTORC1 directly phosphorylates and activates ERalpha upon estrogen stimulation","volume":"35","author":"Alayev","year":"2016","journal-title":"Oncogene"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah6893","article-title":"PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D","volume":"355","author":"Toska","year":"2017","journal-title":"Science"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2015.1084448","article-title":"Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion","volume":"14","author":"Caino","year":"2015","journal-title":"Cell Cycle"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1500722112","article-title":"PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion","volume":"112","author":"Caino","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.777003","article-title":"American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"6","author":"Hammond","year":"2010","journal-title":"J Oncol Pract"},{"key":"B205","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1186\/1471-2407-14-941","article-title":"Metabolic characterization of triple negative breast cancer","volume":"14","author":"Cao","year":"2014","journal-title":"BMC Cancer"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.04.06.db05-1339","article-title":"Gonadal hormones determine sensitivity to central leptin and insulin","volume":"55","author":"Clegg","year":"2006","journal-title":"Diabetes"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1210\/me.2012-1191","article-title":"Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells","volume":"26","author":"O\u2019Mahony","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B208","article-title":"Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy","volume":"49","author":"Neeman","year":"1989","journal-title":"Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(92)90207-y","article-title":"Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging","volume":"43","author":"Furman","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11387","article-title":"Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer","volume":"107","author":"Rivenzon-Segal","year":"2003","journal-title":"Int J Cancer"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2014.11.015","article-title":"Estrogen receptors in breast carcinogenesis and endocrine therapy","author":"Huang","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0031-1299592","article-title":"The role of estrogen receptor-beta in breast cancer","volume":"30","author":"Murphy","year":"2012","journal-title":"Semin Reprod Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.32","article-title":"Estrogen receptor beta activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo","volume":"2","author":"Manente","year":"2013","journal-title":"Oncogenesis"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djw236","article-title":"Estrogen Receptor beta as a Therapeutic Target in Breast Cancer Stem Cells","volume":"109","author":"Ma","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M400221-MCP200","article-title":"Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2\/neu-positive breast cancer","volume":"4","author":"Zhang","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0527","article-title":"Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer","volume":"73","author":"Walsh","year":"2013","journal-title":"Cancer Res"},{"key":"B217","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10549-016-3968-8","article-title":"Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer","volume":"160","author":"O\u2019Neal","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27049","article-title":"Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer","volume":"234","author":"Castagnoli","year":"2019","journal-title":"J Cell Physiol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/ncomms2236","article-title":"Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism","volume":"3","author":"Ding","year":"2012","journal-title":"Nat Commun"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.05.019","article-title":"Inhibition of glycolysis by a novel EGFR\/HER2 inhibitor KU004 suppresses the growth of HER2+ cancer","volume":"357","author":"Tian","year":"2017","journal-title":"Exp Cell Res"},{"key":"B221","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg050","article-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","volume":"95","author":"Foulkes","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2334","article-title":"Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes","volume":"11","author":"Stefansson","year":"2009","journal-title":"Breast Cancer Res"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.10.011","article-title":"Expression of BRCA1 protein in breast cancer and its prognostic significance","volume":"39","author":"Rakha","year":"2008","journal-title":"Hum Pathol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.4161\/cc.22776","article-title":"BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies","volume":"11","author":"Martinez-Outschoorn","year":"2012","journal-title":"Cell Cycle"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.4161\/cc.25695","article-title":"Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and \u201cfibroblast addiction\u201d are new therapeutic targets for drug discovery","volume":"12","author":"Lisanti","year":"2013","journal-title":"Cell Cycle"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apcsb.2016.10.003","article-title":"Transcription Factors in Breast Cancer-Lessons From Recent Genomic Analyses and Therapeutic Implications","volume":"107","author":"Zacksenhaus","year":"2017","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080590","article-title":"Rb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner","volume":"8","author":"Kim","year":"2013","journal-title":"PloS One"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.4161\/15384101.2014.967118","article-title":"RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer","volume":"14","author":"Knudsen","year":"2015","journal-title":"Cell Cycle"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.10.15703","article-title":"RB1 and p53 at the crossroad of EMT and triple-negative breast cancer","volume":"10","author":"Jiang","year":"2011","journal-title":"Cell Cycle"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81568","article-title":"RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation","volume":"126","author":"Jones","year":"2016","journal-title":"J Clin Invest"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.09.002","article-title":"Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis","volume":"3","author":"Zacksenhaus","year":"2017","journal-title":"Trends Cancer"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2016.09.006","article-title":"Functional characterization of AMP-activated protein kinase signaling in tumorigenesis","volume":"1866","author":"Cheng","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1199104","article-title":"Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome","volume":"18","author":"Corradetti","year":"2004","journal-title":"Genes Dev"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308061100","article-title":"The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress","volume":"101","author":"Shaw","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.055","article-title":"LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest","volume":"139","author":"Morton","year":"2010","journal-title":"Gastroenterology"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.83","article-title":"Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN\/LKB1-deficient mice","volume":"104","author":"Garcia-Martinez","year":"2011","journal-title":"Br J Cancer"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056567","article-title":"Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways","volume":"8","author":"Andrade-Vieira","year":"2013","journal-title":"PloS One"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0015","article-title":"Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer","volume":"3","author":"Liu","year":"2013","journal-title":"Cancer Discov"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13858","article-title":"Histone demethylase lysine demethylase 5B in development and cancer","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.04.006","article-title":"KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming","volume":"379","author":"Zhang","year":"2019","journal-title":"Exp Cell Res"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2017.05.004","article-title":"Hypoxic pathobiology of breast cancer metastasis","volume":"1868","author":"Schito","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-7390-6","article-title":"Hypoxia and breast cancer: prognostic and therapeutic implications","volume":"64","author":"Lundgren","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"B247","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-030-12734-3_6","article-title":"Hypoxia and Metabolism in Metastasis","volume":"1136","author":"Zhang","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11246","article-title":"Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma","volume":"97","author":"Bos","year":"2003","journal-title":"Cancer"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1186\/bcr775","article-title":"Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter","volume":"6","author":"Gruber","year":"2004","journal-title":"Breast Cancer Res"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2690","article-title":"Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer","volume":"12","author":"Generali","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B251","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.365","article-title":"HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.442939","article-title":"Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts","volume":"288","author":"Gilkes","year":"2013","journal-title":"J Biol Chem"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0629","article-title":"Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis","volume":"11","author":"Gilkes","year":"2013","journal-title":"Mol Cancer Res"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3963","article-title":"Collagen prolyl hydroxylases are essential for breast cancer metastasis","volume":"73","author":"Gilkes","year":"2013","journal-title":"Cancer Res"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018866109","article-title":"Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia","volume":"109","author":"Conley","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2997","article-title":"Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype","volume":"5","author":"Xiang","year":"2014","journal-title":"Oncotarget"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29080","article-title":"Oncometabolites-driven tumorigenesis: From genetics to targeted therapy","volume":"135","author":"Morin","year":"2014","journal-title":"Int J Cancer"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1038\/nature15726","article-title":"Oxidative stress inhibits distant metastasis by human melanoma cells","volume":"527","author":"Piskounova","year":"2015","journal-title":"Nature"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06248-11","article-title":"Glucose oxidation modulates anoikis and tumor metastasis","volume":"32","author":"Kamarajugadda","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2482","article-title":"Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix","volume":"73","author":"Davison","year":"2013","journal-title":"Cancer Res"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.20","article-title":"Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis","volume":"4","author":"Kamarajugadda","year":"2013","journal-title":"Cell Death Dis"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1007\/BF00121214","article-title":"Acidic pH enhances the invasive behavior of human melanoma cells","volume":"14","author":"Martinez-Zaguilan","year":"1996","journal-title":"Clin Exp Metastasis"},{"key":"B267","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/excr.2002.5508","article-title":"Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited","volume":"276","author":"Stern","year":"2002","journal-title":"Exp Cell Res"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475x.2000.00353.x","article-title":"Lactate elicits vascular endothelial growth factor from macrophages: a possible alternative to hypoxia","volume":"8","author":"Constant","year":"2000","journal-title":"Wound Repair Regener"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.07.007","article-title":"Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment","volume":"99","author":"Ishii","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.16.12553","article-title":"Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells","volume":"9","author":"Martinez-Outschoorn","year":"2010","journal-title":"Cell Cycle"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.17.12721","article-title":"The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism","volume":"9","author":"Pavlides","year":"2010","journal-title":"Cell Cycle"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.12.12.18671","article-title":"Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance","volume":"12","author":"Ko","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","journal-title":"Cancer Res"},{"key":"B276","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-019-1210-3","article-title":"Exosomes from the tumour-adipocyte interplay stimulate beige\/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression","volume":"38","author":"Wu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.4161\/cc.22136","article-title":"Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells","volume":"11","author":"Martinez-Outschoorn","year":"2012","journal-title":"Cell Cycle"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14706","article-title":"Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via beta-hydroxybutyrate","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"B285","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100587","article-title":"HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"B287","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.08.010","article-title":"Tumor-associated macrophages in breast cancer: Innocent bystander or important player","volume":"70","author":"Qiu","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21422","article-title":"Macrophage migration and gene expression in response to tumor hypoxia","volume":"117","author":"Murdoch","year":"2005","journal-title":"Int J Cancer"},{"key":"B290","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","article-title":"Impeding macrophage entry into hypoxic tumor areas by Sema3A\/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity","volume":"24","author":"Casazza","year":"2013","journal-title":"Cancer Cell"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J Clin Invest"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-013-9621-3","article-title":"The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling","volume":"36","author":"Ferrante","year":"2013","journal-title":"Inflammation"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2110","article-title":"Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin","volume":"5","author":"Tripathi","year":"2014","journal-title":"Oncotarget"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B295","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cytogfr.2017.06.005","article-title":"Tumor-derived factors affecting immune cells","volume":"36","author":"Russo","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02251","article-title":"Enzymatic Inactivation of Oxysterols in Breast Tumor Cells Constraints Metastasis Formation by Reprogramming the Metastatic Lung Microenvironment","volume":"9","author":"Moresco","year":"2018","journal-title":"Front Immunol"},{"key":"B297","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat Commun"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-019-09429-z","article-title":"Metformin and Breast Cancer: Molecular Targets","volume":"24","author":"Faria","year":"2019","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.5572","article-title":"Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial","author":"Mariotti","year":"2020","journal-title":"JAMA Oncol"},{"key":"B301","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3390\/cancers12082252","article-title":"Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer","volume":"12","author":"Varghese","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3128-y","article-title":"Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells","volume":"147","author":"Haugrud","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0127","article-title":"Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism","volume":"71","author":"Zhao","year":"2011","journal-title":"Cancer Res"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32270","article-title":"Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression","volume":"145","author":"Arroyo-Crespo","year":"2019","journal-title":"Int J Cancer"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0264","article-title":"A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability","volume":"17","author":"Sirois","year":"2019","journal-title":"Mol Cancer Res"},{"key":"B306","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/ijms20092272","article-title":"Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives","volume":"20","author":"Medeiros","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.602416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:34:24Z","timestamp":1609994064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.602416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":306,"alternative-id":["10.3389\/fonc.2020.602416"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.602416","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"article-number":"602416"}}